An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Previously Untreated Males With Severe Hemophilia A
Clinical trial NCT02234323 · COMPLETED
Trial details
- NCT number
- NCT02234323
- Sponsor
- Bioverativ, a Sanofi company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-12
- Primary completion
- 2019-09-23
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.